[1]
|
Assessing the impact of chemotherapy-induced nausea and vomiting on patients’ quality of life: An Arabic version of the Functional Living Index-Emesis
Journal of Oncology Pharmacy Practice,
2022
DOI:10.1177/1078155221998447
|
|
|
[2]
|
Assessing the impact of chemotherapy-induced nausea and vomiting on patients’ quality of life: An Arabic version of the Functional Living Index-Emesis
Journal of Oncology Pharmacy Practice,
2022
DOI:10.1177/1078155221998447
|
|
|
[3]
|
Glucocorticoid Receptor Expression Predicts Good Outcome in response to Taxane-Free, Anthracycline-Based Therapy in Triple Negative Breast Cancer
Journal of Oncology,
2020
DOI:10.1155/2020/3712825
|
|
|
[4]
|
Adherence to guidelines on prophylaxis of chemotherapy-induced nausea and vomiting in the National Cancer Institute, Sudan
South African Journal of Oncology,
2017
DOI:10.4102/sajo.v1i0.9
|
|
|
[5]
|
Survey of Implementation of Antiemetic Prescription Standards in Indian Oncology Practices and Its Adherence to the American Society of Clinical Oncology Antiemetic Clinical Guideline
Journal of Global Oncology,
2017
DOI:10.1200/JGO.2016.006023
|
|
|
[6]
|
Impact of adherence to antiemetic guidelines on the incidence of chemotherapy-induced nausea and vomiting and quality of life
International Journal of Clinical Pharmacy,
2016
DOI:10.1007/s11096-016-0393-3
|
|
|
[7]
|
Cost-Effectiveness Analysis of Granisetron-Based versus Standard Antiemetic Regimens in Low-Emetogenic Chemotherapy: A Hospital-based Perspective from Malaysia
Asian Pacific Journal of Cancer Prevention,
2013
DOI:10.7314/APJCP.2013.14.12.7701
|
|
|